Sam Jackson

Sam Jackson has an extensive work experience in the medical field. Starting from 2022, Sam has been serving as the Chief Medical Officer at Neuron23. Prior to that, from 2020 to 2022, Sam held the position of Chief Medical Officer at Alector and also served as the Senior Vice President from 2020 to 2021. In 2019, Sam worked as the Chief Medical Officer (part-time) at Excision BioTherapeutics and as the Sr. Engagement Manager (part-time) at Headland Strategy Group. From 2018 to 2019, Sam worked as a Principal at Pharmaxys Consulting. Earlier on, from 2016 to 2018, Sam held the position of Chief Medical Officer at Alkahest, Inc. Before that, from 2014 to 2016, Sam served as the Executive Director of Clinical Development & Drug Safety at Dynavax Technologies. From 2011 to 2014, Sam worked as a Project Team Leader at Genentech. In the earlier part of their career, from 2008 to 2011, Sam was a Global Safety Officer at Amgen. Lastly, from 2006 to 2008, Sam gained valuable experience as a Medical Toxicology Fellow at Banner Health, where they provided care to patients suffering from adverse drug events and provided advice on pharmacotherapy and patient management.

Sam Jackson has a diverse education history. Sam holds an M.D. degree from the University of Pennsylvania School of Medicine, specializing in Medicine. In addition, they have an M.B.A. from The Wharton School, focusing on Business. Sam also completed the American Course on Drug Development and Regulatory Sciences, specializing in Clinical and Industrial Drug Development. Prior to these advanced degrees, they obtained a Bachelor of Arts degree in English from Stanford University.

Furthermore, Sam Jackson has acquired certifications in Emergency Medicine from the American Board of Emergency Medicine in December 2007, and as a Physician and Surgeon from The Medical Board of California in September 2003.

Although no information is provided regarding specific years or completion of degrees at Collegiate School, it is mentioned twice in the education history.